Molecular Origins for the Dominant Negative Function of Human Glucocorticoid Receptor Beta

ABSTRACT This study molecularly elucidates the basis for the dominant negative mechanism of the glucocorticoid receptor (GR) isoform hGRβ, whose overexpression is associated with human glucocorticoid resistance. Using a series of truncated hGRα mutants and sequential mutagenesis to generate a series of hGRα/β hybrids, we find that the absence of helix 12 is neither necessary nor sufficient for the GR dominant negative phenotype. Moreover, we have localized the dominant negative activity of hGRβ to two residues and found that nuclear localization, in addition to heterodimerization, is a critical feature of the dominant negative activity. Molecular modeling of wild-type and mutant hGRα and hGRβ provides structural insight and a potential physical explanation for the lack of hormone binding and the dominant negative actions of hGRβ.

[1]  T. Willson,et al.  Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition , 2002, Cell.

[2]  E. Sternberg.  Faculty Opinions recommendation of High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. , 2001 .

[3]  Christophe Blanchet,et al.  ANTHEPROT: An integrated protein sequence analysis software with client/server capabilities , 2001, Comput. Biol. Medicine.

[4]  A. Steinmetz,et al.  Binding of ligands and activation of transcription by nuclear receptors. , 2001, Annual review of biophysics and biomolecular structure.

[5]  J. Cidlowski,et al.  Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: A mechanism for the generation of glucocorticoid resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Kawamoto,et al.  The Peptide Near the C Terminus Regulates Receptor CAR Nuclear Translocation Induced by Xenochemicals in Mouse Liver , 2001, Molecular and Cellular Biology.

[7]  G. Chrousos,et al.  High Constitutive Glucocorticoid Receptor β in Human Neutrophils Enables Them to Reduce Their Spontaneous Rate of Cell Death in Response to Corticosteroids , 2001, The Journal of experimental medicine.

[8]  Rhian F. Walther,et al.  Glucocorticoid Receptor Homodimers and Glucocorticoid-Mineralocorticoid Receptor Heterodimers Form in the Cytoplasm through Alternative Dimerization Interfaces , 2001, Molecular and Cellular Biology.

[9]  H. Gronemeyer,et al.  Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.

[10]  D. Moras,et al.  Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. , 2000, Molecular endocrinology.

[11]  T. Ashida,et al.  Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis ☆ ☆☆ , 2000 .

[12]  A. Sousa,et al.  Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform , 2000 .

[13]  B. Henderson,et al.  A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals. , 2000, Experimental cell research.

[14]  S. O’Rahilly,et al.  Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension , 1999, Nature.

[15]  D. Ray,et al.  Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation. , 1999, Molecular endocrinology.

[16]  Giovanni Soda,et al.  Exploiting the past and the future in protein secondary structure prediction , 1999, Bioinform..

[17]  J. Cidlowski,et al.  The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. , 1999, The Journal of biological chemistry.

[18]  D T Jones,et al.  Protein secondary structure prediction based on position-specific scoring matrices. , 1999, Journal of molecular biology.

[19]  Christophe Geourjon,et al.  Improved performance in protein secondary structure prediction by inhomogeneous score combination , 1999, Bioinform..

[20]  J. Lafitte,et al.  Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. , 1999, American journal of respiratory and critical care medicine.

[21]  S. Collins,et al.  Retinoid X Receptor (RXR) Agonist-Induced Activation of Dominant-Negative RXR-Retinoic Acid Receptor α403 Heterodimers Is Developmentally Regulated during Myeloid Differentiation , 1999, Molecular and Cellular Biology.

[22]  G. Chrousos,et al.  Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. , 1999, Biochemical and biophysical research communications.

[23]  R J Fletterick,et al.  Nuclear-receptor ligands and ligand-binding domains. , 1999, Annual review of biochemistry.

[24]  P. Sigler,et al.  Atomic structure of progesterone complexed with its receptor , 1998, Nature.

[25]  J. Cidlowski,et al.  Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. , 1998, Molecular endocrinology.

[26]  G. Chrousos,et al.  Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β , 1997, The Journal of experimental medicine.

[27]  Paul S. Charifson,et al.  Practical Application of Computer-Aided Drug Design , 1997 .

[28]  P. Argos,et al.  Seventy‐five percent accuracy in protein secondary structure prediction , 1997, Proteins.

[29]  R. King,et al.  Identification and application of the concepts important for accurate and reliable protein secondary structure prediction , 1996, Protein science : a publication of the Protein Society.

[30]  P. Stierna,et al.  Glucocorticoid Resistant Syndromes—Molecular Basis andClinical Presentations , 1996, Journal of neuroendocrinology.

[31]  M. Stallcup,et al.  GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Cidlowski,et al.  The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. , 1996, The Journal of biological chemistry.

[33]  William Bourguet,et al.  A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.

[34]  M. Danielsen,et al.  Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination. , 1996, Molecular endocrinology.

[35]  J. Gibrat,et al.  GOR method for predicting protein secondary structure from amino acid sequence. , 1996, Methods in enzymology.

[36]  J. Thompson,et al.  Using CLUSTAL for multiple sequence alignments. , 1996, Methods in enzymology.

[37]  B. Katzenellenbogen,et al.  Analysis of Mechanisms That Determine Dominant Negative Estrogen Receptor Effectiveness (*) , 1995, The Journal of Biological Chemistry.

[38]  A. Aguzzi,et al.  Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. , 1995, Genes & development.

[39]  G. Chrousos,et al.  Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. , 1995, The Journal of clinical investigation.

[40]  C Geourjon,et al.  SOPM: a self-optimized method for protein secondary structure prediction. , 1994, Protein engineering.

[41]  J. Cidlowski,et al.  Modulation by vitamin B6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addition to the glucocorticoid receptor. , 1993, The Journal of biological chemistry.

[42]  B. Rost,et al.  Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.

[43]  B. Katzenellenbogen,et al.  Powerful dominant negative mutants of the human estrogen receptor. , 1993, The Journal of biological chemistry.

[44]  S. Detera-Wadleigh,et al.  The genomic structure of the human glucocorticoid receptor. , 1991, The Journal of biological chemistry.

[45]  Klaus Damm,et al.  Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist , 1989, Nature.

[46]  J. Gibrat,et al.  Further developments of protein secondary structure prediction using information theory. New parameters and consideration of residue pairs. , 1987, Journal of molecular biology.

[47]  K. Yamamoto,et al.  Two signals mediate hormone‐dependent nuclear localization of the glucocorticoid receptor. , 1987, The EMBO journal.

[48]  R. Evans,et al.  Primary structure and expression of a functional human glucocorticoid receptor cDNA , 1985, Nature.

[49]  J. Harmon,et al.  Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. , 1985, Science.